D. Keller

Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.

F. Koster, D. Marks, J. Mays, 1994, JAMA.

A controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markers.

M. Kimmel, S. Farmer, D. Warrino, 2010, Methods and findings in experimental and clinical pharmacology.

Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.

M. Versavel, M. DelBello, J. Miceli, 2008, Journal of child and adolescent psychopharmacology.

Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.

M. Versavel, M. DelBello, M. Stewart, 2009, Journal of child and adolescent psychopharmacology.

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study

E. Vieta, A. Loebel, T. Ramey, 2010, Journal of Psychopharmacology.

P.3.c.073 Effects of asenapine on cognitive function in acute schizophrenia: a placebo- and risperidone-controlled trial

S. Potkin, K. Fleming, L. Alphs, 2007, European Neuropsychopharmacology.